MyFinsight
Home
Blog
About
Contact
Download
Download image
Net loss
-$196,039K
Loss before income
taxes
-$195,996K
Income tax provision
$43K
Product
$114,857K
License And Other
$31,210K
Total other (expense)
income, net
-$105,289K
Loss from operations
-$90,707K
Interest income
$2,773K
Other income
(expense), net
$152K
Revenue from contract
with customer,...
$146,067K
(loss) gain on
extinguishment of debt
-$62,365K
Interest expense
$45,849K
Total operating
expenses
$236,774K
Research and development
$125,617K
Selling, general and
administrative
$105,208K
Cost of
sales-Product
$5,949K
Back
Back
Income Statement
source: myfinsight.com
Karyopharm Therapeutics Inc. (KPTI)
Karyopharm Therapeutics Inc. (KPTI)